Clinical TrialsSearch results
Number of results: 253
Other
- Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma
- resectable pancreatic cancer
- Department of surgery, Tohoku University
- 2008-11-13
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Phase II study of irinotecan and tegafur gimeracil for NSCLC with EGFR mutation which resistant to EGFR-TKI
- Non-small-cell lung cancer
- North Japan Lung Cancer Study Group
- 2010-08-31
Other
- Phase II study of imatinib mesylate for treatment of Philadelphia Chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in children: A Japanese Cooperative Trial
- Philadelphia Chromosome-positive acute lymphoblastic leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2005-12-01
Other
- Phase II study of gefitinib in untreated advanced non-small cell lung cancer with EGF receptor mutations
- non-small cell lung cancer
- Hokkaido Lung Cancer Clinical Study Group
- 2005-09-12
Other
- Phase II study of FOLFIRI plus Bevacitumab in the treatment of Japanese patients with advanced colorectal cancer.
- Colorectal cancer
- Japan Clinical Cancer Research Organization
- 2008-10-20
Other
- Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer
- Metastatic gastric cancer (Advanced or recurrent gastric cancer)
- Hiroshima Cancer Therapy Development Organization (HiCTDO)
- 2005-10-01
Other
- Phase II study of Chemotherapy for Advanced or Recurrent Thymoma
- Thymoma (excluding thymic carcinoma)
- Japanese Association for Research on the Thymus
- 2006-04-01
Other
- Phase II study of caffeine combined chemotherapy in patients with high- grade bone and soft tissue tumor
- High-grade bone and soft tissue tumor
- Group for "Caffeine combined chemotherapy in patients with high-grade bone and soft tissue tumor"
- 2008-03-25
Other
- Phase II study of amrubicin for non-small lung cancer after failure of two or three prior chemotherapy regimens
- NSCLC after failure of two or three prior chemotherapy regimes
- Hokkaido Lung Cancer Clinical Study Group
- 2009-08-07